Use of EP3533-Enhanced Magnetic Resonance Imaging as a Measure of Disease Progression in Skeletal Muscle of
EP3533
fibrosis
magnetic resonance image
mdx mouse model
muscular dystrophy
Journal
Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899
Informations de publication
Date de publication:
2021
2021
Historique:
received:
01
12
2020
accepted:
12
05
2021
entrez:
5
7
2021
pubmed:
6
7
2021
medline:
6
7
2021
Statut:
epublish
Résumé
As putative treatments are developed for Duchenne muscular dystrophy (DMD), sensitive, non-invasive measures are increasingly important to quantify disease progression. Fibrosis is one of the histological hallmarks of muscular dystrophy and has been directly linked to prognosis. EP3533 is a novel contrast agent with an affinity to collagen 1 that has demonstrated a significant and high correlation to
Identifiants
pubmed: 34220666
doi: 10.3389/fneur.2021.636719
pmc: PMC8248789
doi:
Types de publication
Journal Article
Langues
eng
Pagination
636719Informations de copyright
Copyright © 2021 Murphy, Greally, O'Hogain, Blamire, Caravan and Straub.
Déclaration de conflit d'intérêts
PC has equity in, and is a consultant to Collagen Medical LLC which holds the patent rights to EP-3533. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Cell Tissue Res. 2010 Feb;339(2):397-410
pubmed: 19902258
Am J Pathol. 2017 Sep;187(9):2060-2070
pubmed: 28826559
Am J Physiol Heart Circ Physiol. 2008 Apr;294(4):H1550-61
pubmed: 18263710
PLoS One. 2018 Mar 26;13(3):e0194540
pubmed: 29579078
Magn Reson Med. 2019 Apr;81(4):2728-2735
pubmed: 30394578
Eur Radiol. 2018 Apr;28(4):1579-1584
pubmed: 29063255
J Neuromuscul Dis. 2016 Mar 3;3(1):1-28
pubmed: 27854210
Ann Neurol. 2016 Apr;79(4):535-47
pubmed: 26891991
J Hepatol. 2015 Sep;63(3):689-96
pubmed: 26022693
Lancet Neurol. 2010 Jan;9(1):77-93
pubmed: 19945913
J Invest Dermatol. 2002 Mar;118(3):461-70
pubmed: 11874485
Eur J Hum Genet. 2013 Oct;21(10):1049-53
pubmed: 23340516
Fibrogenesis Tissue Repair. 2014 Jan 30;7(1):1
pubmed: 24476069
Neuromuscul Disord. 2016 Jul;26(7):414-22
pubmed: 27209345
Biochim Biophys Acta. 2016 Jan;1862(1):1-11
pubmed: 26454207
Radiology. 2008 Jun;247(3):788-96
pubmed: 18403626
J Neurol. 2017 Jan;264(1):64-71
pubmed: 27778157
Exp Neurol. 2008 Aug;212(2):448-57
pubmed: 18571650
FASEB J. 2017 Dec;31(12):5307-5320
pubmed: 28798156
PLoS One. 2018 Mar 19;13(3):e0194283
pubmed: 29554116
Ann Clin Transl Neurol. 2019 May 16;6(6):1033-1045
pubmed: 31211167
Hum Mol Genet. 2001 Jul 15;10(15):1547-54
pubmed: 11468272
Lancet. 2017 Sep 23;390(10101):1489-1498
pubmed: 28728956
Skelet Muscle. 2017 Nov 16;7(1):26
pubmed: 29145886
Am J Respir Cell Mol Biol. 2013 Dec;49(6):1120-6
pubmed: 23927643
Neuromuscul Disord. 2008 Nov;18(11):857-68
pubmed: 18672370
Muscle Nerve. 2013 Sep;48(3):343-56
pubmed: 23681930
J Hepatol. 2012 Sep;57(3):549-55
pubmed: 22634342
NMR Biomed. 2013 Mar;26(3):320-8
pubmed: 23044995
J Hepatol. 2013 Nov;59(5):992-8
pubmed: 23838178
Neuromuscul Disord. 2012 Jan;22(1):16-25
pubmed: 21807516
PLoS One. 2015 Jan 21;10(1):e0117306
pubmed: 25607927
Neurobiol Dis. 2008 Jul;31(1):1-19
pubmed: 18499465
Curr Med Sci. 2019 Feb;39(1):138-145
pubmed: 30868504
Methods Mol Biol. 2018;1687:205-217
pubmed: 29067666
J Neuropathol Exp Neurol. 2009 Jul;68(7):762-73
pubmed: 19535995
Lancet Neurol. 2010 Feb;9(2):177-89
pubmed: 19945914
Sci Rep. 2017 Aug 14;7(1):8114
pubmed: 28808290
Lancet Neurol. 2014 Oct;13(10):987-96
pubmed: 25209738
Muscle Nerve. 2009 May;39(5):591-602
pubmed: 19260102
Lancet Neurol. 2003 Dec;2(12):731-40
pubmed: 14636778
Acta Myol. 2012 Dec;31(3):184-95
pubmed: 23620650
Neuromuscul Disord. 2014 May;24(5):409-16
pubmed: 24613733
PLoS One. 2017 Aug 25;12(8):e0183825
pubmed: 28841698